Inventor profile of:

David STOVER

City:

Encino, California

Country:

United States

Published Applications:

9

Last publication date:

2024-03-07

Top Assignees for applications by David STOVER

The entities that hold a legal rights for patent applications filed by inventor STOVER David:

Recent patent applications by STOVER David

David STOVER from Encino, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2024-03-07
US20240076316A1
Chemistry; metallurgy

Fusion protein composition(s) comprising masked type i interferons (IFNA and IFNB) for use in the treatment of cancer and methods thereof

#2 | 2022-12-22
US20220401451A1
Human necessities

Formulated and/or co-formulated compositions containing A2aR antagonist prodrugs useful in the treatment of cancer and methods thereof

#3 | 2022-06-23
US20220193187A1
Human necessities

Formulated and/or co-formulated liposome compositions containing toll-like receptor (“TLR”) agonist prodrugs useful in the treatment of cancer and methods thereof

#4 | 2022-03-17
US20220080051A1
Human necessities

Formulated and/or co-formulated liposome compositions containing PD-1 antagonist prodrugs useful in the treatment of cancer and methods thereof

#5 | 2022-02-24
US20220056076A1
Chemistry; metallurgy

Fusion protein composition(s) comprising masked type I interferons (IFNA and IFNB) for use in the treatment of cancer and methods thereof

#6 | 2021-08-26
US20210260197A1
Human necessities

Formulated and/or co-formulated liposome compositions containing TFGB antagonist prodrugs useful in the treatment of cancer and methods thereof

#7 | 2021-06-24
US20210187066A1
Human necessities

Formulated and/or co-formulated liposome compositions containing toll-like receptor (“TLR”) agonist prodrugs useful in the treatment of cancer and methods thereof

#8 | 2021-06-03
US20210163418A1
Chemistry; metallurgy

Formulated and/or co-formulated liposome compositions containing IDO antagonist prodrugs useful in the treatment of cancer and methods thereof

#9 | 2020-10-22
US20200331966A1
Chemistry; metallurgy

Fusion protein composition(s) comprising masked type I interferons (IFNA and IFNB) for use in the treatment of cancer and methods thereof

InventorID:

2884294